Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

Bátkai S, Pacher P, Osei-Hyiaman D, Radaeva S, Liu J, Harvey-White J, Offertáler L, Mackie K, Rudd MA, Bukoski RD, Kunos G.

Circulation. 2004 Oct 5;110(14):1996-2002. Epub 2004 Sep 27.

2.

Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats.

Wheal AJ, Bennett T, Randall MD, Gardiner SM.

Br J Pharmacol. 2007 Nov;152(5):717-24. Epub 2007 Aug 13.

3.

Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.

Ho WS, Gardiner SM.

Br J Pharmacol. 2009 Jan;156(1):94-104. doi: 10.1111/j.1476-5381.2008.00034.x.

4.

Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids.

Gaskari SA, Liu H, D'Mello C, Kunos G, Lee SS.

J Hepatol. 2015 Jun;62(6):1272-7. doi: 10.1016/j.jhep.2015.01.021. Epub 2015 Jan 29.

5.

Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.

Herradón E, Martín MI, López-Miranda V.

Br J Pharmacol. 2007 Nov;152(5):699-708. Epub 2007 Aug 20.

6.

Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.

Baranowska-Kuczko M, Kozłowska H, Kloza M, Karpińska O, Toczek M, Harasim E, Kasacka I, Malinowska B.

Life Sci. 2016 Apr 15;151:288-99. doi: 10.1016/j.lfs.2016.03.014. Epub 2016 Mar 9.

PMID:
26969765
7.

Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.

Vlachou S, Nomikos GG, Panagis G.

Psychopharmacology (Berl). 2006 Oct;188(3):293-305. Epub 2006 Sep 5.

PMID:
16953388
8.

Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.

Bátkai S, Mukhopadhyay P, Harvey-White J, Kechrid R, Pacher P, Kunos G.

Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1689-95. Epub 2007 Jun 8.

9.

Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.

Pacher P, Bátkai S, Osei-Hyiaman D, Offertáler L, Liu J, Harvey-White J, Brassai A, Járai Z, Cravatt BF, Kunos G.

Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H533-41. Epub 2005 Apr 8.

10.

Mesenteric vasodilation mediated by endothelial anandamide receptors.

Wagner JA, Varga K, Járai Z, Kunos G.

Hypertension. 1999 Jan;33(1 Pt 2):429-34.

11.

Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis.

Pulgar VM, Yamaleyeva LM, Varagic J, McGee CM, Bader M, Dechend R, Howlett AC, Brosnihan KB.

Hypertension. 2014 Sep;64(3):619-25. doi: 10.1161/HYPERTENSIONAHA.114.03633. Epub 2014 Jun 16.

12.

Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.

Wagner JA, Járai Z, Bátkai S, Kunos G.

Eur J Pharmacol. 2001 Jul 6;423(2-3):203-10.

PMID:
11448486
13.

Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.

Moezi L, Gaskari SA, Liu H, Baik SK, Dehpour AR, Lee SS.

Br J Pharmacol. 2006 Dec;149(7):898-908. Epub 2006 Oct 16.

14.

Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor.

Li J, Kaminski NE, Wang DH.

Hypertension. 2003 Mar;41(3 Pt 2):757-62. Epub 2002 Dec 30.

15.

Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery.

Baranowska-Kuczko M, MacLean MR, Kozłowska H, Malinowska B.

Pharmacol Res. 2012 Sep;66(3):251-9. doi: 10.1016/j.phrs.2012.05.004. Epub 2012 May 22.

PMID:
22627170
16.

Differential endocannabinoid regulation of baroreflex-evoked sympathoinhibition in normotensive versus hypertensive rats.

Brozoski DT, Dean C, Hopp FA, Hillard CJ, Seagard JL.

Auton Neurosci. 2009 Oct 5;150(1-2):82-93. doi: 10.1016/j.autneu.2009.05.243. Epub 2009 May 22.

17.

Effects of hypertension on vasorelaxation to endocannabinoids in vitro.

Wheal AJ, Randall MD.

Eur J Pharmacol. 2009 Jan 28;603(1-3):79-85. doi: 10.1016/j.ejphar.2008.11.061. Epub 2008 Dec 9.

PMID:
19100733
18.

Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts.

Wagner JA, Abesser M, Karcher J, Laser M, Kunos G.

J Cardiovasc Pharmacol. 2005 Sep;46(3):348-55.

PMID:
16116341
19.

Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.

Nucci C, Gasperi V, Tartaglione R, Cerulli A, Terrinoni A, Bari M, De Simone C, Agrò AF, Morrone LA, Corasaniti MT, Bagetta G, Maccarrone M.

Invest Ophthalmol Vis Sci. 2007 Jul;48(7):2997-3004.

PMID:
17591864
20.

CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.

Béquet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C, Scatton B, Le Fur G.

Eur J Neurosci. 2007 Dec;26(12):3458-64. Epub 2007 Dec 4.

PMID:
18052990

Supplemental Content

Support Center